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ABSTRACT 
Background: Fibrosarcoma is a mesenchymal tumor of adult and pediatric age groups 
representing 10 to 12% of all soft-tissue sarcomas. Infantile fibrosarcoma is an 
uncommon tumor of childhood. It represents less than 1% of all childhood cancers but is 
the most common soft-tissue sarcoma in those under 1 year of age. The tumor may be 
observed at birth, in infancy or in childhood, and has been called congenital or infantile 
fibrosarcoma. Fibrosarcoma is one of the types of non-rhabdomyosarcoma soft tissue 
sarcoma (NRTS) that accounts for 3% of all childhood malignancies. Only 5% of all 
primary malignant tumors in children arise in the head and neck. The purpose of this 
paper is to report a rare case of infantile low grade fibromyxosarcoma and the choice of 
diagnostic radiology modalities. 
Case: A 2-month-old boy with the rare case of an infantile low-grade fibromyxoid 
sarcoma (LGFMS). The tumor arose in the paravertebral region of his left posterolateral 
neck. There is no infiltration to the intracranial or vertebral canal. A review of the 
literature indicates that this is one of the youngest patients diagnosed with a tumor of this 
type, and had never been reported as LGFMS.  
Conclusion: A rare case of infantile low grade fibromyxosarcoma had been reported. 
Based on the history, physical examination, laboratory examination, and radiologic 
imaging, the diagnosis of infantile low grade fibromyxosarcoma was established. 
Magnetic Resonance Imaging (MRI) is the best modality overall for examining soft-tissue 
masses and is useful in providing information about the local extent, lesion size, and 
involvement of the neurovascular structures. 
Keywords: Fibromyxoid, sarcoma, childhood, radiology 
 
INTRODUCTION 
Infantile fibrosarcoma is an 
uncommon tumor of childhood. Infantile 
fibrosarcoma represents less than 1% of all 
childhood cancers, but it is the most 
common soft-tissue sarcoma in those under 
1 year of age. Fibrosarcoma is one of the 
types of non-rhabdomyosarcoma soft 
tissue sarcoma (NRTS) that accounts for 
3% of all childhood malignancies. Only 
5% of all primary malignant tumors in 
children arise in the head and neck.1,2 
Fibrosarcoma is a tumor of 
mesenchymal cell origin that is composed 
of malignant fibroblasts in a collagen 
background. It can occur as a soft-tissue 
mass or as a primary or secondary bone 
tumor. Low-grade fibromyxoid sarcoma 
(LGFMS) is a rare soft tissue sarcoma that 
typically affects young adults, equally in 
men and women (median age at 
presentation 34 years). It mostly locates in 
the deep soft tissue, presenting as a slow-
growing, nontender, firm tumor. However, 
LGFMSs also occur in superficial regions 
and in children more often than previously 
recognized.3 
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Some subtypes of pediatric NRSTS 
(e.g., infantile fibrosarcoma) have a 
relatively benign clinical course after 
treatment with surgery alone. NRSTS, like 
rhabdomyosarcoma, can arise in any part 
of the body. Two series, comprising a total 
of 322 pediatric patients, revealed that the 
most common sites were the extremities, 
trunk, and abdomen and pelvis. In these 
series, synovial sarcoma, 
neurofibrosarcoma, malignant fibrous 
histiocytoma, and fibrosarcoma were the 
most frequent histologies.4 
Nonrhabdomyosarcomatous soft 
tissue sarcomas (NRSTS) occurring in 
children are a diverse group of neoplasms 
whose rarity has hindered elucidation of 
the optimal treatment and prognosis. These 
tumors are more frequently encountered in 
adults, and data about their impact on 
children are extrapolated from clinical 
studies that involved an older patient 
population.5 
The etiology of cancer in children 
still is poorly understood, for the most part, 
epidemiology studies have recognized that 
the likely mechanism is multifactorial, 
possibly resulting from potential 
interaction between genetic susceptibility 
traits and environmental exposures.6 
Because the tumor is so rare, 
clinical experience is hacking, and there is 
no established protocol for comparing the 
effectiveness of operative treatment, 
chemotherapy, and radiation. Treatment 
must be selected on an individual basis. 
Although complete resection is rarely 
feasible at diagnosis, conservative surgery 
remains the mainstay treatment for 
infantile fibrosarcoma. An alkylating 
agent-free and anthracycline-free regimen 
is usually effective and should be chosen as 
first-line chemotherapy for inoperable 
tumors.1,7 
Overall prognosis is good, but 
progression or relapse, mainly local, 
remains possible. Infantile fibrosarcoma , 
unlike the adults, has a good prognosis 
when treated with a combination of 
resection and chemotherapy.7 
The purpose of this paper is to 
report a rare case of infantile low grade 
fibromyxosarcoma and the choice of 
diagnostic radiology modalities. 
 
CASE REPORT 
AR, 2-month-old baby boy was 
referred to the Surgery Department with a 
mass in the side of his left neck. The mass 
was noticed since birth. There was a slight 
enlargement of the mass. He had no history 
of fever, decreased of body weight, 
bleeding and there was no respiratory 
distress nor difficulty of feeding.  
History of birth and pregnancy. He 
was born by Caesarean section, was 50 cm 
in length, 4000 grams in weight (with the 
mass). He was the first child of the family. 
His mother’s age was 22 years old, with no 
history of illness during pregnancy. She 
had control routine check-ups from the 
local midwife every month. At 8 months of 
pregnancy she underwent an ultrasound 
examination and was told by the doctor that 
there was a mass on the fetus’ neck.  
Family illness history:  There was 
no history of malignancies in either his 
mother or his father.   
Physical examination. The vital 
signs were within normal limit. There was 
no respiratory distress, enlargement of the 
lymph nodes, liver or spleen. The mass on 
the left neck was firm, not tender and 
immobile. The overlying skin was tight and 
with normal color. The mass size was about 
17 cm in diameter. There were no palpable 
masses in other parts of the body. 
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Figure 1. The mass on the left neck 
The anthopometric 
measurements revealed a good 
nutritional state and he weighed 5800 
grams and his length was 52 cm. The 
laboratory findings Hb 11,1   WBC 
10.900, platelet count 393.000. 
SGOT/SGPT: 34/50 Ur/Cr: 9,7/0,13. 
Albumin: 3,45. From these findings, the 
working diagnose for this patient was 
left posterolateral neck tumor. The boy 
then underwent an ultrasound 
examination. The result was a solid mass 
with minimal intratumor vascular.  
 
 
Figure 2. The ultrasound results of the 
mass in the left side of the neck 
The consultation with the radiology 
department concluded that a head MRI 
was needed to determine whether the 
tumor was connected to the nervous 
system and bone.  The results of the head 
MRI revealed a homogenous well 
defined mass, isotense on T1W1 and 
isohyperintense on T2W1 with 
heterogenous enhancement after contrast 
administration, on the left posterolateral 
neck, the size is average 11x17x23 cm. 
The mass was outside of the brain and 
cervical vertebrae. The cerebrum, 
ventricle and medulla spinalis within 
normal limit. The MRI conclusion was a 
left posterolateral embrional tumor colli 
outside of the brain and cervical 
vertebrae with differential diagnosis 
rhabdomyoma.  
 
 
Figure 3. The MRI results 
An incisional biopsy operation was 
planned. Macrossly was appeared a solid 
white mass. Under the microscope, the 
slice showed a tissue consisted of 
proliferation of spindle cell inside 
fybrocollagen tissue and stellate cell 
inside myxoid tissue. The biopsy 
concluded low grade fibromyxosarcoma. 
Therefore, a resection surgery and 
chemotherapy were planned. At the age 
of 3 months, the boy underwent a 
complete resection of the mass. The 
mass was solid and weighed 500 grams.  
 
Figure 4. The resected mass 
 
After the operation, the boy underwent 
chemotherapy course for fibrosarcoma 
consisting of cyclophosphamide, 
adryamicin,vincristine and DTIC. After 
completing this full course for 4 months, 
the patient underwent an evaluation by 
MRI. The MRI showed no residual mass.  
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Figure 5. Left: The boy after full course 
chemotherapy. Right: Scar tissue after 
surgery. 
 
Fibrosarcoma is a mesenchymal tumor 
of adult and pediatric age groups 
representing 10 to 12% of all soft-tissue 
sarcomas. It represents less than 1% of 
all childhood cancers but is the most 
common soft-tissue sarcoma in those 
under 1 year of age. In more than one-
third of patients, it is present at birth and 
a second peak of incidence occurs 
between 10 and 15 years of life. The 
tumor may be observed at birth, in 
infancy or in childhood, and has been 
called congenital or infantile 
fibrosarcoma. 75% in children less than 
10 years old including 36% in newborns 
(congenital fibrosarcoma). Ratio of boys 
to girls is 1.2 : 1, it is locally aggressive 
with a rare metastatic spread and a good 
rate of survival. The location of 
fibrosarcoma in children, ranked by 
frequency is in the lower extremities, 
upper extremities, head and neck, trunk, 
pelvic area but rarely the retroperitoneal 
or visceral area and  chest. 1,9 
DISCUSSION  
In this case, the patient had mass 
in the neck since birth with a slight 
enlargement of the mass. No history of 
fever, decreased of body weight or 
bleeding, and there was no respiratory 
distress nor difficulty of feeding.  
Fibrosarcoma, like other soft-
tissue sarcomas, has no definite cause. 
Current research indicates that many 
sarcomas are associated with genetic 
mutations and the more common genetic 
defects include allele loss, point 
mutations, and chromosome 
translocations However, no definite 
cause of fibrosarcoma is known, 
although genetic mutations may play a 
role. Several inherited syndromes are 
associated with sarcomas., for example, 
patients with multiple neurofibromas 
may have a 10% lifetime risk of 
developing a neurosarcoma or a 
fibrosarcoma.10.11 
In this case, the cause of the 
tumor is still unknown and there was no 
history of malignancies in either his 
mother’s and father’s families.   
The diagnostic evaluation for 
soft tissue tumors should delineate the 
extent of the primary tumor and the 
extent of metastatic disease and should 
consist of the following: 
1. Complete history 
2. Physical examination 
3. Laboratory studies  
4. Imaging studies : plain 
radiograph, Magnetic resonance 
imaging (MRI) and/or computed 
tomography (CT) of primary 
lesion, and ultrasonography 
(USG) 
5. Biopsy , histopathological 
examination 
Laboratory studies are generally 
not helpful during the initial evaluation, 
and plain radiographs of the involved 
anatomic region are needed to evaluate 
for primary or secondary bone 
involvement. For soft-tissue masses, size 
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often can be estimated, any bone 
involvement can be seen and 
intralesional content (matrix) can 
sometimes be determined. For bony 
lesions, plain radiographs often greatly 
assist in the diagnosis and the 
determination of location, size, and local 
extent of involvement. 9,10 
MRI is the best modality overall 
for examining soft-tissue masses and for 
detecting the intraosseous and 
extraosseous extent of many bony 
sarcomas. Also, MRI is useful in 
providing information about the local 
extent, lesion size, and involvement of 
the neurovascular structures In addition, 
MRI may have value in predicting the 
extent and probability of surgical 
resection for extremity, abdominopelvic, 
and retroperitoneal tumors because of its 
enhanced ability to differentiate tumors 
from normal surrounding tissue 
compared to CT Scan. Furthermore, it is 
useful for evaluating spinal cord 
involvement with retroperitoneal or 
paraspinal tumors.  Although imaging 
findings are not specific of infantile 
fibrosarcoma, diagnosis can indicated 
when MR imaging depicts a large well-
circumscribed mass arising in a limb at 
birth or during the neonatal period. This 
mass is sometimes heterogeneous and 
septate and exhibits an isointense T1- 
and hyperintense T2-weighted signals 
and strong enhancement. MR is also the 
technique of choice for follow-ups 
during treatment which consist 
nowadays almost exclusively in 
chemotherapy. 10,11,12 
CT scanning is used to delineate 
bone involvement, bone destruction, or 
bone reaction especially for sarcomas 
arising in bone. The density of 
fibrosarcomas is similar to that of 
surrounding normal muscle. Signs of 
fracture or impending fracture may be 
seen, and the tumor can be more 
accurately localized. Some authors have 
suggested the use of gadolinium and 
ultrasound scans for diagnosis, but to 
date, the value of these tests for the 
staging of sarcomas remains limited. 10,11 
Ultimately, the diagnosis of 
fibrosarcoma is made with tissue 
obtained from a biopsy. Biopsies should 
be thought of as the first step towards 
treatment, rather than the last step in 
diagnosis. A biopsy should always 
follow a full radiographic workup and 
any biopsy performed must include an 
adequate volume of tissue. In centers 
with expert interpretation, core-needle 
biopsy or fine-needle aspiration may be 
acceptable The value of fine-needle 
aspiration is primarily to differentiate a 
solid mass from a fluid containing mass 
or an abscess for drainage. In all other 
instances, a minimum of a True-Cut 
needle biopsy is warranted.. An 
excisional biopsy of a lesion is 
undertaken only in those instances when 
the tumor is small (<2.5 cm) or situated 
so that an eventual wide local resection 
can be done without risk or functional 
deformity. In all other instances, an 
incisional biopsy is obtained and is 
carefully planned and placed, so that the 
tract can be completely excised at the 
time of definitive surgery.5, 10 
Fibrosarcomas are tumors of 
malignant fibroblasts and collagen 
which vary in histologic grade. Infantile 
fibrosarcoma is histologically similar to 
those seen in adults.  Fibrosarcoma 
occurred mainly in the muscles of the 
extremities . This congenital form shows 
uniform fibroblasts or myofibroblast 
with  low rate of mitosis. 9,10  
The tumor shows a biphasic pattern with 
fi brous and myxoid areas, minimal 
nuclear pleomorphism, low to moderate 
cellularity, and a swirling, whorled 
growth (A: HE, ×200). The background 
matrix ranges from fibromyxoid to 
densely fibrous (B: HE, ×400) 
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Figure 6. Histopathological slice of fibrosarcoma 
There were some differential diagnosis 
for fibrosarcoma :  
 Nodular fascitis 
 Myositis ossificans 
 Inflammatory pseudotumor 
 Neurofibrosarcoma 
 Malignant peripheral nerve 
sheath tumor/schwannoma 
 Poorly differentiated embryonal 
rhabdomyosarcoma 
 Monophasic (spindle cell) 
synovial sarcoma 
Many parameters are helpful in 
the differential diagnosis of infantile 
fibrosarcoma. However, the number of  
inflammatory cells, histologic pattern 
and age of the patient is helpful in 
differential diagnosis of infantile 
fibrosarcoma 2,5,8,9,10 
In this case, the diagnosis of 
infantile fibrosarcoma was established 
from history taking, physical 
examinations, imaging and also a biopsy. 
The mass in the left neck was palpated as 
a firm, non-tender and immobile mass, 
the overlying skin was tight and within 
normal color. The mass size was about 
17 cms in diameter and there were no 
other palpable masses in other parts of 
his body. The ultrasound examination 
result showed a solid mass with minimal 
intratumor vascular, followed by a head 
MRI with conclusion: a left 
posterolateral embrional tumor colli 
outside the brain and cervical vertebrae, 
differential diagnosed as rhabdomyoma. 
An incisional biopsy operation was 
planned.  And the histopathological 
examination revealed a low grade 
fibromyxosarcoma. 
Nonrhabdomyosarcomatous soft 
tissue sarcomas (NRSTS) occurring in 
children are a diverse group of 
neoplasms whose rarity has hindered 
elucidation of the optimal treatment and 
prognosis. The general management of 
fibrosarcoma consists of surgery, 
chemotherapy and radiotherapy. 
Previously reported series of treatment 
outcomes in infantile fibrosarcoma have 
been limited to very few patients due to 
the rare occurrence of this tumor and 
initial chemotherapy combined with 
surgery has been successful in most 
cases. Unlike that for 
rhabdomyosarcoma, which is a highly 
chemosensitive tumor, the mainstay of 
treatment for NRSTS is complete 
surgical resection with or without 
adjuvant radiotherapy to prevent local 
recurrence.1,14, 15 
Chemotherapy is more widely 
used in children than in adults because 
children better tolerate the acute adverse 
effects and, in general, have malignant 
diseases that are more responsive to 
chemotherapy than are malignant 
diseases of adults. In general, 
radiotherapy is used sparingly in 
children because they are more 
vulnerable than adults to its late adverse 
effects. 2 
Wide local excision is the 
primary form of treatment, but in some 
cases, as in our case, it is impossible to 
remove lesion because of the anatomic 
extent of these tumors without disrupting 
peripheral vessels and nerves. 
Sometimes, the adjacent bone also has to 
be excised and in larger series of patients 
with infantile fibrosarcoma, the primary 
and secondary amputation rate is 
approximately 50%. In irresectable 
tumors, in relapses and after incomplete 
surgery, chemotherapy, and in older 
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children, radiotherapy is an adjuvant 
therapeutic tool.1,13 
The treatment choice of fibrosarcoma is 
still complete excision of the tumor but 
an initial chemotherapy can convert the 
surgical approach from mutilating 
approaches to more conservative 
surgery, or it can be curative for distant 
metastasis 14-16 
In this case, the patient 
underwent a resection surgery and 
chemotherapy. At the age of 3 months, 
the boy underwent a complete resection 
of the mass then followed by a 4 month 
regimen of chemotherapy that consisted 
of cyclophosphamide, adryamicin, 
vincristine and DTIC.   
Infantile fibrosarcoma’s clinical 
course is more favorable with a rare 
metastatic spread. The local recurrence 
rate is high, up to 43%, and recurrence 
may occur as late as 15 to 31 years after 
the initial operation. However, 
fibrosarcoma occurring in infants has an 
excellent outcome despite histological 
findings. Initial complete excision 
should be attempted in all children and 
recurrence indicates a more aggressive 
variant and warrants more aggressive 
complete re-excision wherever possible. 
The overall disease-specific survival for 
children with NRSTS of the head and 
neck at M. D. Anderson was 80% at 2 
years and 75% at 5 years1,16, 17,18 
Prognostic factors in children with 
NRSTS include the presence or absence 
of etastatic disease, surgical 
respectability of the lesion, histological 
grade, tumor invasiveness, and size of 
the lesion. For congenital fibrosarcoma 
in children, the prognosis (which is 
related to age and to time of diagnosis) is 
much better, with the disease having 
long-term survival rates of higher than 
50%.5, 10, 20 
As with all sarcomas of the 
musculoskeletal system, successful 
treatment of fibrosarcoma must be 
accompanied by an organized plan for 
clinical follow-up. This often involves a 
schedule of repeat examinations and 
diagnostic studies. Patients often are 
monitored for a minimum of 5 years and 
at preset intervals, the patient is 
reexamined, and plain radiographs of the 
involved site are obtained. Repeat 
staging studies of the local area and of 
the chest also are performed. 10 
In this patient, the boy had 
completed the chemotherapy course. The 
patient underwent an evaluation by MRI. 
The MRI showed no residual mass. The 
boy still control routinely to the pediatric 
department. 
  
A rare case of infantile low grade 
fibromyxosarcoma had been reported. 
Based on the history, physical 
examination, laboratory examination, 
and radiologic imaging, the diagnosis of 
infantile low grade fibromyxosarcoma 
was established. MRI is the best 
modality overall for examining soft-
tissue masses and is useful in providing 
information about the local extent, lesion 
size, and involvement of the 
neurovascular structures. In addition, 
MRI may have value in predicting the 
extent and probability of surgical 
resection for these tumors compared to 
CT Scan. Furthermore, it is useful for 
evaluating spinal cord involvement with 
retroperitoneal or paraspinal tumors. 
 
 
SUMMARY 
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